Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Change in Accured Expenses (2023 - 2025)

Historic Change in Accured Expenses for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $1.4 million.

  • Camp4 Therapeutics' Change in Accured Expenses rose 8995.82% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 47460.32%. This contributed to the annual value of $1.5 million for FY2024, which is 122573.53% up from last year.
  • According to the latest figures from Q3 2025, Camp4 Therapeutics' Change in Accured Expenses is $1.4 million, which was up 8995.82% from $1.0 million recorded in Q2 2025.
  • Camp4 Therapeutics' 5-year Change in Accured Expenses high stood at $1.8 million for Q4 2024, and its period low was -$2.8 million during Q1 2025.
  • Over the past 3 years, Camp4 Therapeutics' median Change in Accured Expenses value was $639500.0 (recorded in 2023), while the average stood at $212500.0.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first surged by 22758.01% in 2024, then crashed by 72187.5% in 2025.
  • Quarter analysis of 3 years shows Camp4 Therapeutics' Change in Accured Expenses stood at $562000.0 in 2023, then soared by 227.58% to $1.8 million in 2024, then dropped by 26.02% to $1.4 million in 2025.
  • Its Change in Accured Expenses stands at $1.4 million for Q3 2025, versus $1.0 million for Q2 2025 and -$2.8 million for Q1 2025.